Biotech Growth Trust (The) (BIOG)

Business description

The Biotech Growth Trust seeks capital appreciation through investing in the worldwide biotechnology industry, mainly in emerging biotechnology companies. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).

Stock data

Market cap.£450.8m
Last close807.25p
High / Low (52 weeks)807.2p / 573.0p
Stock market listingLN
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Alliance Trust Altamir SCA
Amphion Innovations APQ Global
Aurelius Bailador Tech Investments
Bankers Investment Trust (The) BB Biotech
BlackRock Greater Europe Investment Trust BlackRock Hedge Selector
BlackRock Latin American Inv. Trust British Portfolio Trust
Brunner Investment Trust (The) Canadian General Investments
Carador Income Fund Charles Stanley
Circle Property City Natural Resources
Conversus Capital CQS Rig Finance Fund
CVC Credit Partners Detour Gold
Deutsche Beteiligungs Dexion Commodities
Diverse Income Trust (The) DouglasBay Capital
Dunedin Enterprise Investment Trust DW Catalyst Fund
Edinburgh Worldwide Investment Trust (The) European Assets Trust
European Investment Trust Plc (The) F&C Managed Portfolio Growth
F&C Managed Portfolio Income F&C US Smaller Companies
Fidelity China Special Situations Fidelity European Values
Finsbury Growth & Income Trust Foreign & Colonial Investment Trust
Gartmore Growth Opportunities Gartmore Irish Growth Fund
Geiger Counter Limited GLI Alternative Finance
Global Resources Investment Trust Golden Prospect Precious Metals
Hansa Trust HarbourVest Global Private Equity
HarbourVest Senior Loans Europe HBM Healthcare Investments
Heliad Equity Partners Henderson Alternative Strategies Trust
Henderson Far East Income Henderson Global Trust
Henderson Global Trust Henderson International Income Trust
HSBC Infrastructure Company Infrastructure India
International Biotechnology Trust Invesco Asia Trust
Invesco Income Growth Trust Is Private Equity
JP Morgan Private Equity Limited JPMorgan Brazil Investment Trust
JPMorgan European Smaller Companies Trust JPMorgan Global Convertibles Income Fund
JPMorgan Global Growth & Income JPMorgan Indian Investment Trust
Jupiter Green Investment Trust Jupiter UK Growth Investment Trust
Jupiter US Smaller Companies JZ Capital Partners Limited
Lazard World Trust Fund Leaf Clean Energy Company
LMS Capital Lowland Investment Company
LPEQ Martin Currie Asia Unconstrained Trust
Martin Currie Global Portfolio Trust Middlefield Canadian Income
Miton Global Opportunities Miton Income Opportunities Trust
New City Energy Ocean Wilsons Holdings
Pacific Assets Trust Phaunos Timber Fund
Polar Capital Global Healthcare Trust PXP Vietnam Fund
Qatar Investment Fund Rathbone Brothers
RENN Universal Growth Investment Trust Schroder AsiaPacific Fund
Schroder Global Real Estate Securities ScotGems
Scottish Oriental Smaller Companies Securities Trust of Scotland
Seneca Global Income & Growth Trust Sigma Capital Group
Standard Life Equity Income Trust Standard Life Investments Property Income Trust
Standard Life Pvt. Equity Trust Standard Life UK Smaller Companies Trust
Strategic Equity Capital Taiwan Fund (The)
Templeton Emerging Markets Investment Trust Tetragon Financial Group
The Law Debenture Corporation The Merchants Trust
The North American Income Trust The Scottish Investment Trust
Tiso Blackstar Group TR European Growth trust
UK Commercial Property Trust Utilico Emerging Markets
Vietnam Holding Asset Management Vietnam Infrastructure Fund
VinaCapital Vietnam Opportunity Fund VinaLand
Vision Opportunity China Fund WAM Active
WAM Capital WAM Research
Witan Investment Trust Witan Pacific Investment Trust
Worldwide Healthcare Trust YFM Equity Partners

Company news

£10000 into £31000 in three years: can this fund keep rising?

Wed, 24 Sep 2014 09:10:33 GMT

Are biotech funds set to bounce back over the rest of 2016?

Thu, 16 Jun 2016 11:11:14 GMT

DIRECTOR DEALINGS: Biotech Growth Trust Non-Exec Purchases Shares

Fri, 26 May 2017 16:18:45 GMT

Private investor's diary: Onwards and upwards

Fri, 13 Jan 2017 07:42:45 GMT

The Diary of a Private Investor: Biotech stands accused of being a bubble but ...

Thu, 16 Apr 2015 16:55:24 GMT

Investment summary

The Biotech Growth Trust (BIOG) is a specialist vehicle, aiming to generate long-term capital growth via investment in global biotech stocks. Following a particularly volatile period for the biotech industry, where concerns about drug pricing and investor risk aversion have weighed heavily on stock prices, the managers are hopeful that greater clarity regarding US healthcare policy will lead to continued improved performance of biotech stocks. Industry fundamentals remain attractive, including continued innovation and valuations are very supportive, which offers the potential for higher industry merger and acquisition activity.

Last updated on 21/02/2017

Key management

Andrew Joy, Chairman
Richard Klemm, Fund manager
Geoffrey Hsu, Fund manager

Company address

One Wood Street
London
EC2V 7WS
United Kingdom
View website